User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer.

  1. Cosyns, Drug Safety, 26, 33 (2003)
  2. Arlt, Mutagenesis, 17, 265 (2002)
  3. Stengel, Nephrologie, 19, 15 (1998)
  4. Bieler, Carcinogenesis, 18, 1063 (1997)
  5. Nortier, N Engl J Med, 342, 1686 (2000)
  6. Cosyns, Am J Kidney Dis, 33, 1011 (1999)
  7. Lord, Lancet, 358, 1515 (2001)
  8. IARC, IARC Sci Publ, 82 (2002)
  9. Kessler, N Engl J Med, 342, 1742 (2000)
  10. Letter to Health Care Professionals on FDA concerned about botanical products, including dietary supplements, containing aristolochic acids. US Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling and Dietary Supplements, 31 May 2000.
  11. Gold, N Engl J Med, 349, 1576 (2003)
  12. Pfau, Carcinogenesis, 11, 1627 (1990)
  13. Stiborova, Carcinogenesis, 24, 1695 (2003)
  14. Nortier, Nephrol Dial Transplant, 18, 426 (2003)
  15. Ghersi-Egea, Bio Pharm, 45, 647 (1993)
  16. Schmeiser, Cancer Res, 50, 5464 (1990)
  17. Debelle, Arch Toxicol, 77, 218 (2003)
  18. Vineis, Int J Cancer, 88, 325 (2000)
  19. Arlt, Carcinogenesis, 22, 133 (2002)
  20. Lord, Am J Kidney Dis, 43, e11 (2004)
  21. Liu, PNAS, 101, 2963 (2004)
  22. Lebeau, Kidney Int, 60, 1332 (2001)
Bibliographic reference Arlt, Volker M ; Alunni-Perret, Véronique ; Quatrehomme, Gérald ; Ohayon, Patrick ; Albano, Laetitia ; et. al. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer.. In: International journal of cancer. Journal international du cancer, Vol. 111, no. 6, p. 977-80 (2004)
Permanent URL http://hdl.handle.net/2078.1/27764